[ Price : $8.95]
Relmada Therapeutics says a Phase 3 trial in Major Depressive Disorder shows that patients treated daily with REL-1017 for up to o...[ Price : $8.95]
Taysha Gene Therapies says it is discontinuing the development of its gene therapy TSHA-120 program as a treatment for giant axona...[ Price : $8.95]
UCB says its BLA for plaque psoriasis drug bimekizumab is facing another FDA review extension.[ Price : $8.95]
Federal Register notice: FDAs Office of Womens Health and Office of Clinical Pharmacology announces a 10/11 public workshop: Menop...[ Price : $8.95]
Medline Industries recalls its Hudson RCI Addipak unit dose vial, 0.9% full normal saline solution (Lot 3B085) due to sterility co...[ Price : $8.95]
Federal Register notice: CBER requests information from stakeholders about critical scientific challenges and opportunities to adv...[ Price : $8.95]
FDA warns Tempe, AZ-based PureChemPros it is illegally manufacturing and distributing unapproved and misbranded new drugs that vio...[ Price : $8.95]
Federal Register notice: FDA releases its FDA Information Technology Strategy, which is open for comments until 10/30.